Cell Surface Markers Market – Top 3 Players and there Market Growth

03.12.2019 - 13:59 | 1776237

Artikel von marketsandmarkets

The increasing funding for life sciences research, high global prevalence of cancer, and growth in stem cell and neurobiology research.

The increasing funding for life sciences research, high global prevalence of cancer, and growth in stem cell and neurobiology research.

Market Size
The global Cell Surface Markers market size is projected to reach USD 769 million by 2023 from USD 520 million in 2018, at a CAGR of 8.1%

Thermo Fisher Scientific (US), QIAGEN N.V. (Netherlands), Becton, Dickinson and Company (US), F. Hoffman-La Roche (Switzerland), Bio-Rad Laboratories (US), Danaher Corporation (US), Abcam (UK), GenScript (China), BioLegend (US), Cell Signaling Technology (US), Merck KGaA (Germany), and Bio-Techne (US) are some key players in this market. These companies are focusing on increasing their presence in the high-growth markets through both organic as well as inorganic growth strategies such as product launches, acquisitions, and expansions.

For More Details, Download a PDF Brochure:-

“Thermo Fisher Scientific is one of the leading players in the cell surface markers market”
The company’s strong brand recognition and extensive product portfolio is its key strength. In order to maintain its leading position in this market, Thermo Fisher adopts organic and inorganic growth strategies such as acquisitions and expansions. For instance, in the last three years, the company acquired Affymetrix (US) and the Advanced Bioprocessing business from Becton, Dickinson and Company (US). Such acquisitions help Thermo Fisher in strengthening its Life Sciences Solutions segment for versatile product offerings. The company’s efforts towards enhancing its financial strategies have also significantly helped in sustaining its existing position within this market.

“Becton, Dickinson and Company (BD) is one of the prominent players in the cell surface markers market”
BD offers a robust product portfolio and has a strong geographical presence in this market. Its products are marketed internationally and in the US through independent distribution channels; they are also marketed directly to end users by the company itself, and also by independent sales representatives. The primary end users of the company’s products are hospitals, laboratories and clinics, blood banks, healthcare workers, public health agencies, academic and government institutions, and pharmaceutical and biotechnology companies.

We can help with your specific research requirement for this market. Please share your specific interest to help us serve you better, Request Sample Pages:-

Unternehmensinformation / Kurzprofil:

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, and strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.


PresseKontakt / Agentur:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
Email: sales(at)marketsandmarkets.com


Vor- / Nachname: marketsandmarkets

Ansprechpartner: Mr. Shelly Singh
Stadt: northbrook
Telefon: 8886006441

Keywords (optional):
cell-surface-markers-market, cell-surface-markers, t-cell-surface-markers, cancer-cell-surface-markers, immunology, stem-cells, oncology, hematology,

Dieser Artikel wurde bisher 69 mal aufgerufen.


Direkter Link zu diesem Artikel:

Diese Pressemeldung bookmarken bei...

Tausendreporter BlinkList del.icio.us Folkd Furl Google Linkarena Mister Wong oneview Yahoo MyWeb YiGG Webnews Technorati

Über einen Link auf Ihrer News-, Presse- oder Partner-Seite würden wir uns sehr freuen.

Hiermit versichert der Erfasser, dass der eingestellte Artikel der Wahrheit entspricht. Er ist frei von Rechten Dritter und steht zur Veröffentlichung bereit. Die Haftung für eventuelle Folgen (z.B. Abmahnungen, Schadenersatzforderungen etc.) übernimmt der Eintrager und nicht internet-intelligenz.de

[ Anfrage per Mail | Fehlerhaften Artikel melden | Druckbare Version | Diesen Artikel an einen Freund senden ]

Alle Artikel von marketsandmarkets RSS Feed

FDA bestätigt das Phagenyx® System, welches mittels Behandlung von neurogener Dysphagie die sichere Entfernung der Beatmungskanüle beschleunigt, als Breaktrough Device
Evolution 2.0 Prize: Erstmalige Dotierung von 10 Mio. US-Dollar für das Replizieren der zellulären Evolution
LumiThera schließt zweite Tranche einer Serie C-Finanzierung ab
Dr. Mark Bittinger wechselt als globaler Leiter des Bereichs Biologie zu Sai Life Sciences
Jennewein Biotechnologie setzt ihre Patente im Bereich humaner Milchzucker gegen Nestlé in Deutschland durch

Blogverzeichnis - Blog Verzeichnis bloggerei.deBlog Top Liste - by TopBlogs.de